San Diego, CA, United States of America

Omar D Perez

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2014-2019

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Insights into the Innovations of Omar D. Perez

Introduction

Omar D. Perez, based in San Diego, CA, is a notable inventor with a robust portfolio of six patents. His work predominantly focuses on advancements in gene therapy and modified cytosine deaminases, which hold significant potential in the treatment of various diseases and disorders.

Latest Patents

Among his latest innovations are patents related to recombinant vectors and gene therapy vectors. These disclosures provide groundbreaking modifications to cytosine deaminases (CDs) and detail the methods of utilizing these modified CDs within cells and vectors. The implications of this work could revolutionize therapeutic approaches in modern medicine.

Career Highlights

Omar has contributed significantly to the biotechnology sector through his role at Tocagen Inc., where he plays a key part in translating scientific innovations into viable treatments. His expertise in genetic engineering and therapeutic vectors positions him as a leader in his field.

Collaborations

Throughout his career, Omar has collaborated with esteemed colleagues, including Douglas J. Jolly and Harry E. Gruber. These partnerships enhance the potential for innovation and expansion of ideas in their shared pursuits within the biotechnology landscape.

Conclusion

Omar D. Perez exemplifies the spirit of innovation that drives advancements in healthcare and biotechnology. His contributions, particularly in gene therapy technologies, reflect a commitment to improving treatment options for patients and highlight the importance of collaborative efforts in achieving significant breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…